Table 2 Status of abatacept administration
Duration of treatment with abatacept | Patients who discontinued treatment with abatacept | Reasons for discontinuation | ||||||
|---|---|---|---|---|---|---|---|---|
n | % | Occurrence of adverse events | Remission | Insufficient | Loss to follow-up | Transfer to other hospitals | Other | |
< 12 weeks | 8 | 9.8 | 1 | 0 | 7 | 1 | 0 | 0 |
≥ 12 weeks, < 24 weeks | 3 | 3.7 | 2 | 0 | 1 | 1 | 0 | 1 |
≥ 24 weeks, < 36 weeks | 4 | 4.9 | 0 | 0 | 4 | 0 | 0 | 0 |
≥ 36 weeks, < 48 weeks | 5 | 6.1 | 0 | 0 | 1 | 0 | 2 | 2 |
≥ 48 weeks, < 52 weeks | 0 | 0.0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 20 | 24.4 | 3 | 0 | 13 | 2 | 2 | 3 |